Interaction of rocuronium with sevoflurane as quantified by closed-loop feedback control ROCSEVO 1.0/ 2008-003341-88

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2008-003341-88-FI

Enrollment

Registered

2008-06-10

Start date

2008-07-09

Completion date

Unknown

Last updated

2014-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ei erityisryhmiä. Potilaat tulevat elektiiviseen korva-nenä-kurkkualueen leikkaukseen, jonka kesto on arviolta vähintään 90 minuuttia. Potilaat kuuluvat ASA-luokkaan I-III. Tietyt perustaudit estävät mukaantulon, sellaisia ovat mm. merkittävä sydämen, maksan tai munuaisten vajaatoiminta. Tarkemmin asiaa selostetaan tutkimussuunnitelmassa. MedDRA version: 9.1 Level: LLT Classification code 10053322 Term: Otorhinolaryngological surgery

Interventions

Trade Name: Esmeron Pharmaceutical Form: INN or Proposed INN: ROCURONIUM BROMIDE CAS Number: 119302919 Trade Name: Sevorane Pharmaceutical Form: INN or Proposed INN: SEVOFLURANE CAS Number: 2852386

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026